Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

VYGR – Voyager Therapeutics Inc.

VYGR — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

7.61

Margin Of Safety %

Put/Call OI Ratio

0.2

EPS Next Q Diff

-0.01

EPS Last/This Y

0.38

EPS This/Next Y

0.1

Price

3.27

Target Price

14.89

Analyst Recom

1.09

Performance Q

-17.42

Upside

-2,219.3%

Beta

1.31

Ticker: VYGR




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13VYGR3.250.040.078717
2026-07-14VYGR3.150.040.038950
2026-07-15VYGR3.190.040.029114
2026-07-16VYGR3.040.040.009104
2026-07-17VYGR3.180.040.029471
2026-07-20VYGR3.040.060.035830
2026-07-21VYGR3.120.051.306314
2026-07-22VYGR3.10.100.106686
2026-07-23VYGR3.080.110.446811
2026-07-24VYGR3.110.120.907003
2026-07-27VYGR3.10.170.067340
2026-07-28VYGR3.040.170.007447
2026-07-29VYGR30.170.227448
2026-07-30VYGR3.130.175.567465
2026-07-31VYGR3.030.220.007788
2026-08-03VYGR2.990.220.077799
2026-08-04VYGR3.130.220.057805
2026-08-05VYGR3.090.220.007830
2026-08-06VYGR3.110.220.007834
2026-08-07VYGR3.280.200.098388
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13VYGR3.2510.9- -1.66
2026-07-14VYGR3.1410.9- -1.66
2026-07-15VYGR3.1910.9- -1.66
2026-07-16VYGR3.0410.9- -1.66
2026-07-17VYGR3.1710.9- -1.66
2026-07-20VYGR3.0510.9- -1.66
2026-07-21VYGR3.1310.9- -1.66
2026-07-22VYGR3.1010.9- -1.66
2026-07-23VYGR3.0910.9- -1.66
2026-07-24VYGR3.1110.9- -1.66
2026-07-27VYGR3.0910.9- -1.66
2026-07-28VYGR3.0410.9- -1.66
2026-07-29VYGR3.0010.9- -1.66
2026-07-30VYGR3.1310.9- -1.66
2026-07-31VYGR3.0310.9- -1.66
2026-08-03VYGR3.0010.9- -1.66
2026-08-04VYGR3.0010.9- -1.66
2026-08-05VYGR3.0810.9- -1.66
2026-08-06VYGR3.1210.9- -1.66
2026-08-07VYGR3.2710.9- -1.66
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13VYGR-0.79-2.547.09
2026-07-14VYGR-0.79-2.547.09
2026-07-15VYGR-0.79-2.547.09
2026-07-16VYGR-0.79-2.547.09
2026-07-17VYGR-0.79-2.547.09
2026-07-20VYGR-0.79-2.547.09
2026-07-21VYGR-0.79-2.547.09
2026-07-22VYGR-0.79-2.547.09
2026-07-23VYGR-0.79-2.547.09
2026-07-24VYGR-0.79-2.547.09
2026-07-27VYGR-0.79-2.887.61
2026-07-28VYGR-0.79-2.887.61
2026-07-29VYGR-0.79-2.887.61
2026-07-30VYGR-0.79-2.887.61
2026-07-31VYGR-0.79-2.887.61
2026-08-03VYGR-0.79-3.567.61
2026-08-04VYGR-0.79-3.567.61
2026-08-05VYGR-0.79-3.567.61
2026-08-06VYGR-0.79-3.567.61
2026-08-07VYGR-0.79-3.567.61
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.47

Avg. EPS Est. Current Quarter

-0.51

Avg. EPS Est. Next Quarter

-0.48

Insider Transactions

-0.79

Institutional Transactions

-3.56

Beta

1.31

Average Sales Estimate Current Quarter

4

Average Sales Estimate Next Quarter

10

Fair Value

Quality Score

16

Growth Score

32

Sentiment Score

71

Actual DrawDown %

77.2

Max Drawdown 5-Year %

-80.5

Target Price

14.89

P/E

Forward P/E

PEG

P/S

5.41

P/B

1.14

P/Free Cash Flow

EPS

-1.98

Average EPS Est. Cur. Y​

-1.66

EPS Next Y. (Est.)

-1.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-319.61

Relative Volume

0.73

Return on Equity vs Sector %

-94.5

Return on Equity vs Industry %

-78.4

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.07

EBIT Estimation

VYGR Healthcare
$3.27
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
2/20
Pullback
11/25
Volume
9/15
Valuation
12/20
TP/AR
2/10
Options
7/10
RSI
51.9
Range 1M
38.7%
Sup Dist
5.8%
🚀
Momentum Growth
Ride accelerating trends
N/A
29 /100
WEAK
Momentum
1/25
Growth
17/30
Estimates
0/20
Inst/Vol
1/15
Options
10/10
EPS Yr
16.9%
EPS NY
20%
52W%
12.8%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +355.4% upside
Quality
6/30
Valuation
16/30
Growth
11/25
Stability
6/10
LT Trend
1/5
Upside
+355.4%
Quality
16
VYGR — P/E HistoricalBiotechnology
Voyager Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 141
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
VYGR

Latest News

Caricamento notizie per VYGR
stock quote shares VYGR – Voyager Therapeutics Inc. Stock Price stock today
news today VYGR – Voyager Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VYGR – Voyager Therapeutics Inc. yahoo finance google finance
stock history VYGR – Voyager Therapeutics Inc. invest stock market
stock prices VYGR premarket after hours
ticker VYGR fair value insiders trading

 VYGR – Voyager Therapeutics, Inc.

VYGR — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

7.61

Margin Of Safety %

Put/Call OI Ratio

0.2

EPS Next Q Diff

-0.01

EPS Last/This Y

0.38

EPS This/Next Y

0.1

Price

3.27

Target Price

14.89

Analyst Recom

1.09

Performance Q

-17.42

Upside

-2,219.3%

Beta

1.31

Ticker: VYGR




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13VYGR3.250.040.078717
2026-07-14VYGR3.150.040.038950
2026-07-15VYGR3.190.040.029114
2026-07-16VYGR3.040.040.009104
2026-07-17VYGR3.180.040.029471
2026-07-20VYGR3.040.060.035830
2026-07-21VYGR3.120.051.306314
2026-07-22VYGR3.10.100.106686
2026-07-23VYGR3.080.110.446811
2026-07-24VYGR3.110.120.907003
2026-07-27VYGR3.10.170.067340
2026-07-28VYGR3.040.170.007447
2026-07-29VYGR30.170.227448
2026-07-30VYGR3.130.175.567465
2026-07-31VYGR3.030.220.007788
2026-08-03VYGR2.990.220.077799
2026-08-04VYGR3.130.220.057805
2026-08-05VYGR3.090.220.007830
2026-08-06VYGR3.110.220.007834
2026-08-07VYGR3.280.200.098388
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13VYGR3.2510.9- -1.66
2026-07-14VYGR3.1410.9- -1.66
2026-07-15VYGR3.1910.9- -1.66
2026-07-16VYGR3.0410.9- -1.66
2026-07-17VYGR3.1710.9- -1.66
2026-07-20VYGR3.0510.9- -1.66
2026-07-21VYGR3.1310.9- -1.66
2026-07-22VYGR3.1010.9- -1.66
2026-07-23VYGR3.0910.9- -1.66
2026-07-24VYGR3.1110.9- -1.66
2026-07-27VYGR3.0910.9- -1.66
2026-07-28VYGR3.0410.9- -1.66
2026-07-29VYGR3.0010.9- -1.66
2026-07-30VYGR3.1310.9- -1.66
2026-07-31VYGR3.0310.9- -1.66
2026-08-03VYGR3.0010.9- -1.66
2026-08-04VYGR3.0010.9- -1.66
2026-08-05VYGR3.0810.9- -1.66
2026-08-06VYGR3.1210.9- -1.66
2026-08-07VYGR3.2710.9- -1.66
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13VYGR-0.79-2.547.09
2026-07-14VYGR-0.79-2.547.09
2026-07-15VYGR-0.79-2.547.09
2026-07-16VYGR-0.79-2.547.09
2026-07-17VYGR-0.79-2.547.09
2026-07-20VYGR-0.79-2.547.09
2026-07-21VYGR-0.79-2.547.09
2026-07-22VYGR-0.79-2.547.09
2026-07-23VYGR-0.79-2.547.09
2026-07-24VYGR-0.79-2.547.09
2026-07-27VYGR-0.79-2.887.61
2026-07-28VYGR-0.79-2.887.61
2026-07-29VYGR-0.79-2.887.61
2026-07-30VYGR-0.79-2.887.61
2026-07-31VYGR-0.79-2.887.61
2026-08-03VYGR-0.79-3.567.61
2026-08-04VYGR-0.79-3.567.61
2026-08-05VYGR-0.79-3.567.61
2026-08-06VYGR-0.79-3.567.61
2026-08-07VYGR-0.79-3.567.61
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.47

Avg. EPS Est. Current Quarter

-0.51

Avg. EPS Est. Next Quarter

-0.48

Insider Transactions

-0.79

Institutional Transactions

-3.56

Beta

1.31

Average Sales Estimate Current Quarter

4

Average Sales Estimate Next Quarter

10

Fair Value

Quality Score

16

Growth Score

32

Sentiment Score

71

Actual DrawDown %

77.2

Max Drawdown 5-Year %

-80.5

Target Price

14.89

P/E

Forward P/E

PEG

P/S

5.41

P/B

1.14

P/Free Cash Flow

EPS

-1.98

Average EPS Est. Cur. Y​

-1.66

EPS Next Y. (Est.)

-1.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-319.61

Relative Volume

0.73

Return on Equity vs Sector %

-94.5

Return on Equity vs Industry %

-78.4

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.07

EBIT Estimation

VYGR Healthcare
$3.27
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
2/20
Pullback
11/25
Volume
9/15
Valuation
12/20
TP/AR
2/10
Options
7/10
RSI
51.9
Range 1M
38.7%
Sup Dist
5.8%
🚀
Momentum Growth
Ride accelerating trends
N/A
29 /100
WEAK
Momentum
1/25
Growth
17/30
Estimates
0/20
Inst/Vol
1/15
Options
10/10
EPS Yr
16.9%
EPS NY
20%
52W%
12.8%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +355.4% upside
Quality
6/30
Valuation
16/30
Growth
11/25
Stability
6/10
LT Trend
1/5
Upside
+355.4%
Quality
16
VYGR — P/E HistoricalBiotechnology
Voyager Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 141
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
VYGR

Latest News

Caricamento notizie per VYGR
stock quote shares  VYGR – Voyager Therapeutics, Inc. Stock Price stock today
news today  VYGR – Voyager Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch  VYGR – Voyager Therapeutics, Inc. yahoo finance google finance
stock history  VYGR – Voyager Therapeutics, Inc. invest stock market
stock prices VYGR premarket after hours
ticker VYGR fair value insiders trading